Bracco Imaging SpA, a renowned player in the field of diagnostic imaging worldwide, has entered into a comprehensive agreement with Subtle Medical, Inc., a pioneering force in the realm of artificial intelligence (AI)-enhanced imaging. This global accord, initially centered in the United States, where Bracco Imaging disseminates its array of products and services through its subsidiary, Bracco Diagnostics Inc., is focused on advancing magnetic resonance imaging (MRI).

Contrast-enhanced MRI relies on contrast agents to accentuate specific tissues or anomalies, offering superior visualization and more comprehensive diagnostic insights. The integration of AI within this domain holds the potential to revolutionize image interpretation, enhancing accuracy, efficiency, and patient care. Through this strategic alliance, Bracco Imaging and Subtle Medical can harness each other's intellectual assets to pursue these ambitious objectives.

Fulvio Renoldi Bracco, Vice President and CEO of Bracco Imaging SpA, emphasized, "The fusion of Bracco's proficiency in contrast imaging with Subtle Medical's deep learning technology, when applied to MRI imaging, undeniably stands to benefit physicians and their patients. Through this collaboration, we are committed to redefining the benchmarks of diagnostic precision and efficacy, opening up new avenues and augmenting the value of our already exceptional MRI portfolio."

Enhao Gong, CEO of Subtle Medical, Inc., expressed his satisfaction with the partnership, stating, "Subtle Medical is delighted to join forces with Bracco, a global leader in contrast development and commercialization. This agreement marks a significant milestone for both companies as we unite to empower medical professionals and enhance patient outcomes worldwide, leveraging Subtle Medical's platform and innovative suite of AI products for MRI and beyond."

 

Source: prnewswire.com

Report Abuse